23andMe Paves the Way for Direct-to-Consumer Genetic Health Risk Tests of Limited Clinical Utility
Ann Intern Med
.
2017 Jul 18;167(2):125-126.
doi: 10.7326/M17-1045.
Epub 2017 May 30.
Authors
Julia Wynn
1
,
Wendy K Chung
1
Affiliation
1
From Columbia University, New York, New York.
PMID:
28554190
DOI:
10.7326/M17-1045
No abstract available
MeSH terms
Direct-To-Consumer Screening and Testing*
Genetic Predisposition to Disease
Genetic Testing*
Genotype
Humans
Marketing
United States
United States Food and Drug Administration